Homozygous MTHFR C677T & A1298C: High-Risk Variants and Your Cardiovascular Health

Written by Dan Purser

By Dan Purser MD

There's a big clinical difference between having one copy of an MTHFR mutation (heterozygous) and having two copies (homozygous). If your lab results show you are homozygous C677T or homozygous A1298C, you can't afford to rely on internet guesswork, trial-and-error supplements, or a local doctor who dismisses genetics.

Heterozygous vs. Homozygous: What It Means

You inherit one copy of the MTHFR gene from each parent.

  • Heterozygous: one variant copy, one typical copy.

  • Homozygous: two variant copies.

  • Compound heterozygous: one C677T and one A1298C.

How much does enzyme activity drop?

Homozygous mutations are severe bottlenecks. At this level, enzyme efficiency can drop substantially. The original 1995 research found that people with two copies of C677T had roughly 30% of normal enzyme activity in lab testing, versus about 65% for one copy (Frosst et al., 1995). That matches the "70% drop" figure I use for homozygous C677T. My textbook puts homozygous C677T at a 30–70% reduction in enzyme activity. A1298C is different: on its own it has a milder effect, but it becomes significant when combined with C677T (compound heterozygosity) (Purser, Genetic Architecture of Hyperhomocysteinemia).

The Cardiovascular Stakes of Unmanaged Homozygous Genetics

When your methylation pathway is this restricted, homocysteine can build up to harmful levels. This isn't just about feeling tired. Severe hyperhomocysteinemia is associated with heart attacks, strokes, hypertension, and kidney disease.

A major meta-analysis found that higher homocysteine was associated with greater risk of ischemic heart disease and stroke (Homocysteine Studies Collaboration, 2002). Reviews tie high homocysteine to hypertension through impaired nitric oxide and stiffer arteries (Sen et al., 2010), and kidney disease and homocysteine feed each other, since failing kidneys clear less of it (Friedman et al., 2001).

Silent damage

Worse, this vascular damage can be silent. Your doctor might run a standard lipid panel and tell you your cholesterol is fine, missing the cytokine-driven damage in your blood vessels. Homocysteine has been shown to make the cells lining human arteries release MCP-1 and IL-8, two inflammatory signals tied to plaque (Poddar et al., 2001).

What the trials say

To be balanced: trials that lowered homocysteine with B vitamins have had mixed results. HOPE-2 did not reduce overall cardiovascular events (HOPE-2 Investigators, 2006), while CSPPT found fewer first strokes when folic acid was added to blood-pressure treatment (Huo et al., 2015). I believe the missing piece is addressing the inflammation, not only the number.

The Need for a Physician-Led Protocol

Over my decades of practice, I have treated very complex homozygous cases using precise biochemistry. You can't treat a double mutation with a single vitamin.

What a structured protocol includes

Safely managing this genetic risk requires a structured plan to lower high homocysteine:

  1. Measure intracellular nutrient absorption to see what your cells actually lack.

  2. Use intracellular antioxidants like SOD and glutathione to help protect blood vessels.

  3. Carefully titrate active methyl donors to avoid pushing your nervous system into overmethylation.

  4. Monitor homocysteine and adjust over time.

Dosing is individualized at consultation.

Questions to ask your doctor

  • What is my homocysteine level, and what's my target?

  • Do I have other methylation variants beyond MTHFR?

  • Should my family members be tested?

  • How often should we re-check?

For daily food and lifestyle steps, read How to Lower Homocysteine Naturally: 7 Steps.

Beyond MTHFR: Other Genes in the Pathway

MTHFR is the best-known gene, but it isn't alone. Other genes involved in B12 handling, homocysteine recycling, and the transsulfuration pathway can add to the bottleneck. That's why the curated methylation panel I designed looks at the pathway as a whole rather than a single gene. The 22 homozygous SNPs I track include MTHFR C677T and A1298C plus variants in AHCY, BHMT, CBS (two), CTH, FOLH1, GGH (three), GNMT, MAT1A, MTHFD1, MTHFD1L, MTHFS, MTR, MTRR (two), SHMT1, SLC19A1, and TCN2 (Purser, Genetic Architecture of Hyperhomocysteinemia).

Riboflavin: A Key Helper for Homozygous C677T

The enzyme made by the C677T variant is unstable partly because it holds on to its riboflavin (B2) helper less tightly. In people homozygous for C677T, riboflavin lowered homocysteine, particularly when riboflavin status was low (McNulty et al., 2006). It's one of the clearest examples of nutrition working with genetics.

Who Should Get Tested

  • Anyone with high homocysteine

  • People with early heart attack, stroke, or clots in themselves or close relatives

  • Relatives of someone known to be homozygous

  • Women with a history of recurrent pregnancy loss; a meta-analysis linked high homocysteine to recurrent early pregnancy loss (Nelen et al., 2000)

  • Patients with unexplained chronic inflammation

If you're in that last group and keep hearing that everything "looks normal," your genes are worth checking. A standard panel won't tell you whether you carry one copy of a variant or two.

What Your Results Mean

Homozygous C677T (TT)

Markedly reduced enzyme activity and a higher chance of high homocysteine. A priority for structured care.

Homozygous A1298C (CC)

Generally a milder effect on homocysteine than TT, but it still matters, especially with other variants. My textbook describes A1298C as mild on its own but significant when combined with C677T (Purser, Genetic Architecture of Hyperhomocysteinemia).

Compound heterozygous (one of each)

Can behave somewhere in between.

Homocysteine level

Tells me how the genetics are actually playing out in your body right now.

Intracellular results typically come back in 10–14 days. Vitamin re-testing should come after 90–100 days of high-level supplementation.

An Example

A 49 yo woman learned she was homozygous C677T after her brother had a stroke at 46. Her homocysteine was well above range, although she felt mostly fine. Active folate and B12, riboflavin and B6, antioxidant support and blood pressure coordination with her primary doctor dropped her homocysteine substantially (this was probably NOT a genetically caused homocysteine problem).

Living With Homozygous MTHFR

Your genes don't change, but your outcome isn't fixed. Most people with homozygous variants can keep homocysteine in a healthy range with consistent support, monitoring, and healthy habits: not smoking, staying active, controlling blood pressure, and eating whole foods. For daily steps, see How to Lower Homocysteine Naturally: 7 Steps.

Talking to Your Family

Because MTHFR variants are inherited, your result may matter for parents, siblings, and children. If you're homozygous, each of your children inherited at least one copy from you. Consider sharing your results and encouraging relatives, especially those with heart disease, stroke, or clotting history, to discuss homocysteine testing with their doctors.

Emergency Warning Signs

Homozygous MTHFR doesn't cause symptoms you can feel day to day, but its complications can be sudden. Call 911 for:

  • Chest pain or pressure

  • Sudden weakness or numbness, especially on one side

  • Trouble speaking or understanding speech

  • Sudden severe headache or vision loss

  • A painful, swollen leg or sudden shortness of breath

Myths About Homozygous MTHFR

Myth: Homozygous means a heart attack is inevitable. It means higher risk, especially with high homocysteine. Managing it changes the picture.

Myth: If I feel fine, I don't need to do anything. Vascular damage can be silent.

Myth: Folic acid from fortified bread covers it. For many homozygous patients, active forms and cofactors work better.

Myth: Testing once is enough. Re-check homocysteine and vitamin levels after 90–100 days of high-level supplementation, and periodically after that.

Working With Your Other Doctors

I encourage patients to share their results and plan with their primary doctor, cardiologist, or obstetrician. Good care is coordinated care, and lowering homocysteine works best alongside blood-pressure, cholesterol, and blood-sugar management.

Questions to Bring to Your Consultation

  • Am I homozygous, heterozygous, or compound heterozygous?

  • What is my homocysteine level today, and what's our target?

  • Which cofactors are low inside my cells?

  • Should my relatives be tested?

  • How will we coordinate with my cardiologist or primary doctor?

The Bottom Line

Two copies of an MTHFR variant is a reason for structured care, not panic. Measure homocysteine, test what your cells need, support the pathway carefully, and re-test after 90–100 days of high-level supplementation. With the right plan, most people can keep their numbers where they should be.

Why Homocysteine Matters for Your Kidneys and Blood Pressure

Patients with homozygous MTHFR often ask whether their genes affect their kidneys or blood pressure. In my experience, high homocysteine often travels with hypertension and kidney strain, and kidney disease itself tends to raise homocysteine, creating a cycle. Published reviews support both directions: kidney disease reduces homocysteine clearance (Friedman et al., 2001), and high homocysteine is linked to hypertension through impaired nitric oxide signaling (Sen et al., 2010). If you have kidney disease, your supplement plan should be coordinated with your nephrologist, because some nutrients need adjustment when kidney function is reduced.

Diet Still Counts

Even with a strong genetic bottleneck, food matters. Leafy greens, beans, lentils, eggs, and other whole foods supply natural folate, B vitamins, and cofactors. Highly processed foods add little and, when fortified, bring the synthetic folic acid many homozygous patients do better limiting. For practical food steps, see my 7 Steps guide.

Knowledge is protective. Knowing you're homozygous gives you a head start most people never get: the chance to measure, monitor, and act long before a problem becomes an emergency.

Take Your Genetic Risk Seriously

If heart disease, stroke, or clots run in your family, or you've simply been told your labs are fine while you feel anything but, knowing your genotype takes the guesswork out. My DRP Genetic Test looks at MTHFR along with the methylation, detox, and inflammation genes I find most useful, and it comes with a consult with me so we can walk through what your results actually mean for you.

Frequently Asked Questions

How often should homocysteine be re-checked?

Results typically come back in 10–14 days; re-test vitamins after 90–100 days of high-level supplementation.

Is homozygous MTHFR C677T serious?

It can be. Two copies sharply reduce enzyme activity and raise the chance of high homocysteine, which is associated with heart disease and stroke.

What's the difference between C677T and A1298C?

They are different spots in the same gene. C677T generally has a larger effect on enzyme activity and homocysteine.

Does homozygous MTHFR mean I'll have a heart attack?

No. It raises risk, especially if homocysteine is high. Managing homocysteine and inflammation is the goal.

Should my children be tested?

Discuss it with your physician. Because the gene is inherited, family testing is often reasonable.

How is homozygous MTHFR treated?

With a structured, physician-led plan: testing, active nutrient forms, antioxidant support, careful dosing, and monitoring.

About the Author Dan Purser MD is a physician who has spent decades researching homocysteine, methylation, and hard-to-diagnose inflammatory illness. He is the author of 30+ books, including the textbook HOMOCYSTEINE and Outlive Your Toxic Genetics, and has authored 23 research manuscripts on homocysteine and inflammation. He has earned 1,400+ five-star reviews across social media. He is the Top-Ranked MD in the USA (by Google Reviews), with more than 1,400 five-star reviews.

Sources (verified on PubMed):

From Dr. Purser's own work:

  • Purser DC. Genetic Architecture of Hyperhomocysteinemia: Mechanisms, 22 Polymorphisms, and Clinical Implications. Chapter in HOMOCYSTEINE (textbook).

Medical disclaimer: This article is for educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. Do not start, stop, or change any medication or supplement without talking to your own physician. Supplement dosing is individualized at consultation.

Dan Purser
Next

How to Lower Homocysteine Naturally: 7 Steps From the Author of the New HOMOCYSTEINE Textbook